Deborah C. Mash

Joe interviews Deborah C. Mash, Ph.D., leading researcher in addiction and brain disorders. She talks about ibogaine research challenges, the need for partnerships, and collecting Phase II and III data. Also discusses her study on Cocaethylene, deaths related to iboga, and the French use of noribogaine. Deb Mash shares her experience at a psychedelics science event and highlights the potential of Ibogaine for addiction treatment. Talks about the risks and challenges of using Ibogaine, conservation efforts within the indigenous community, and the challenges of implementing an ibogaine initiative.

Dr. Deborah Mash, a leading expert on ibogaine and CEO of DemeRx Inc., shares her groundbreaking insights on using ibogaine for addiction treatment. She discusses its historical roots and the promising results from clinical trials, highlighting its potential to alleviate opioid withdrawal symptoms. The conversation touches on the relationship between addiction and mental health, advocating for innovative therapeutic strategies. Dr. Mash also emphasizes the need for medical supervision and ongoing research to harness psychedelics safely in modern medicine.